Immature Pomegranate Extract for Antitumor Applications
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a cost-effective and time-efficient method to valorize immature pomegranate fruits from the fruit thinning process, as they are currently considered waste products and have not been fully explored for their bioactive compounds, which are potentially beneficial for health and pharmaceutical applications.
Innovation Solution
An extraction process involving immature pomegranate fruits, where the fruits are harvested between 30 to 40 days after fruit appearance, mixed with an extraction medium, and subjected to mechanical stirring or ultrasound for several hours to obtain an extract rich in granatins, gallotannins, and ellagic acid derivatives, which can be used in nutraceutical and pharmaceutical formulations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of substance
If immature pomegranate fruits are discarded as waste from the fruit thinning process, then waste management costs are reduced, but valuable bioactive compounds are lost
Solution Approach 1:
The invention converts the harmful waste disposal problem into a beneficial resource by extracting valuable bioactive compounds (punicalagins, ellagic acid, polyphenols) from immature pomegranate fruits that would otherwise be discarded during fruit thinning operations
Solution Approach 2:
The invention recovers valuable compounds from discarded immature fruits by implementing an extraction process that captures bioactive substances before the fruits are completely wasted, thereby transforming waste into a valuable extract
2Quantity of substance
If freeze-drying is used to process immature pomegranate fruits, then bioactive compound extraction is achieved, but processing time and costs increase
Solution Approach 1:
The invention replaces expensive, time-consuming freeze-drying equipment with a simpler, more economical extraction system using common solvents and basic filtration apparatus, achieving comparable extraction efficiency without the high time and cost investment
Solution Approach 2:
The invention changes the extraction parameters from extreme conditions (freeze-drying at very low temperatures) to milder conditions (room temperature or controlled temperature extraction with solvents), achieving effective compound extraction while significantly reducing processing time and energy consumption
3Productivity
If the Folin-Ciocalteau method is used to evaluate total polyphenol content, then results are obtained quickly, but measurement precision and reproducibility decrease
Solution Approach 1:
The invention replaces the colorimetric Folin-Ciocalteau method with HPLC (high-performance liquid chromatography) detection, substituting a simple but imprecise chemical test with a more sophisticated analytical technique that provides accurate quantification of specific polyphenolic compounds while maintaining reasonable analysis speed
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process yields extracts with high antitumor activity, reducing cancer cell proliferation and providing a valuable use for previously discarded fruits, making them suitable for industrial-scale production and therapeutic applications.
Implementation Method 1
adding a sample of vegetable material comprising said one or more immature pomegranate fruits harvested from 30 to 40 days after fruit appearance or parts thereof to an extraction medium
Implementation Method 2
maintaining the suspension under mechanical stirring for 12 to 36 hours
Implementation Method 3
exposing to ultrasounds for 15 to 90 minutes
Implementation Method 4
exposing to ultrasounds for 15 to 90 minutes
Data Source
AI summary
The present invention concerns an extract from pomegranate (Punica granatum L), specifically obtained from one or more immature pomegranate fruits. This extract is obtained through an extraction process including steps a)-d) as described in the text and it may contain gallotannins, ellagitannins, ellagic acid derivatives and granatins. Pharmaceutical and nutraceutical compositions and food supplements comprising this extract fall within the scope of the present invention as well as their use in various fields, more specifically for the treatment of tumors.


